Urogen Pharma Ltd Revenue per Employee (URGN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Urogen Pharma Ltd   (NASDAQ: URGN)
 

Urogen Pharma Ltd 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 227.16% in the third quarter 2026, year on year to cumulative value of $250 million, Urogen Pharma Ltd 's revenue per employee grew on a trailing twelve months basis to $ 859,498. The productivity of Urogen Pharma Ltd 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 189 other companies have achieved higher revenue per employee. While Urogen Pharma Ltd 's total ranking has deteriorated compared to the previous quarter from 677 to 1680. Urogen Pharma Ltd has 291 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

URGN Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 227.16 % 206.17 % 155.07 % 54.03 % 9.91 %
Sales per Employee (TTM) $ 859,498 647,137 479,471 373,299 327,691
URGN's Total Ranking # 1680 # 677 # 1226 # 876 #
Seq. Revenue Change 22.83 % 42.57 % 34.31 % 39.09 % 14.95 %

URGN Company Profile >> Back to URGN Efficiency Comparisons >> Compare URGN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 112
Healthcare Sector # 190
Overall Market # 1680

Revenue per Employee Statistics
High Average Low
$ 647,137 $ 260,465 $ 28,034
(Jun 30 2026)   (Dec 31 2017)



Financial Statements
Urogen Pharma Ltd 's Revenue MRQ $ 89 Millions Visit URGN's Income Statement
Urogen Pharma Ltd 's Revenues TTM $ 250 Millions Visit URGN's aggregate revenue growth
What are URGN's Sales? Visit URGN's Sales by Segment




Other Ratios
Urogen Pharma Ltd 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
URGN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for URGN's Competitors
Revenue per Employee for URGN's Suppliers
Revenue per Employee for URGN's Customers

You may also want to know
URGN's Sales Growth Rates URGN's Pe Price to earnings ratio URGN's Receivables Turnover Ratio URGN's Stock Quote
URGN's Net Income Growth Rates URGN's Ps Price to Sales ratio URGN's Sales per Employee URGN's Asset Turnover Ratio
URGN's Net Margin URGN's Pb Price to Book ratio URGN's Financial Strength Ratios URGN's Dividend Payout Ratio
Date modified: 2026-11-07T13:22:54+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Indivior Pharmaceuticals Inc   1,376,000.00 $ 1,376.000  Million 1,000 
Biogen Inc   1,372,973.33 $ 10,297.300  Million 7,500 
Supernus Pharmaceuticals inc   1,326,849.69 $ 865.106  Million 652 
Corcept Therapeutics Inc  1,320,064.38 $ 963.647  Million 730 
Travere Therapeutics Inc   1,309,927.57 $ 651.034  Million 497 
Lantheus Holdings Inc   1,309,212.07 $ 1,561.890  Million 1,193 
Ptc Therapeutics inc   1,166,048.44 $ 1,155.554  Million 991 
Abbvie Inc   1,158,140.35 $ 66,014.000  Million 57,000 
Biomarin Pharmaceutical Inc  1,134,780.19 $ 3,655.127  Million 3,221 
Bridgebio Pharma Inc   1,126,984.51 $ 945.540  Million 839 
Arvinas Inc   1,119,105.69 $ 275.300  Million 246 
Regeneron Pharmaceuticals Inc   1,096,443.87 $ 16,896.200  Million 15,410 
Ani Pharmaceuticals Inc  1,073,549.48 $ 1,041.343  Million 970 
Verastem Inc   983,294.12 $ 100.296  Million 102 
Syndax Pharmaceuticals Inc   971,244.97 $ 289.431  Million 298 
Ardelyx inc   957,505.11 $ 468.220  Million 489 
Axsome Therapeutics Inc   935,424.86 $ 865.268  Million 925 
Alphatec Holdings Inc   919,662.65 $ 839.652  Million 913 
Insmed Inc  888,846.15 $ 1,479.040  Million 1,664 
Carlisle Companies Incorporated  883,644.07 $ 5,213.500  Million 5,900 
Alkermes Plc   855,414.15 $ 1,753.599  Million 2,050 
Pfizer Inc  848,333.33 $ 63,625.000  Million 75,000 
Transmedics Group Inc   810,300.67 $ 727.650  Million 898 
Cerus Corporation  787,493.06 $ 226.798  Million 288 
Ars Pharmaceuticals Inc   749,300.61 $ 122.136  Million 163 
Phathom Pharmaceuticals Inc   740,919.14 $ 274.881  Million 371 
Emergent Biosolutions Inc   721,222.22 $ 649.100  Million 900 
Intuitive Surgical Inc   711,803.07 $ 12,115.600  Million 17,021 
Johnson and Johnson  705,504.26 $ 99,335.000  Million 140,800 
Mannkind Corporation  698,260.14 $ 413.370  Million 592 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.